Nektar Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Nektar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nektar Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Nektar Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $3.0k | 3.2k | 0.93 |
2023-12-31 | $139k | 246k | 0.57 |
2023-09-30 | $29k | 49k | 0.59 |
2023-06-30 | $5.7k | 9.9k | 0.58 |
2023-03-31 | $7.7k | 11k | 0.70 |
2022-12-31 | $26k | 11k | 2.26 |
2022-09-30 | $48k | 15k | 3.26 |
2022-06-30 | $47k | 12k | 3.78 |
2022-03-31 | $101k | 19k | 5.41 |
2021-12-31 | $267k | 20k | 13.53 |
2021-09-30 | $606k | 34k | 17.97 |
2021-06-30 | $2.5M | 144k | 17.14 |
2021-03-31 | $1.8M | 88k | 20.00 |
2020-12-31 | $2.1M | 124k | 17.01 |
2020-09-30 | $2.0M | 123k | 16.59 |
2020-06-30 | $658k | 28k | 23.16 |
2020-03-31 | $1.5M | 84k | 17.85 |
2019-12-31 | $5.3M | 250k | 21.15 |
2019-09-30 | $3.3M | 181k | 18.19 |
2019-06-30 | $3.1M | 87k | 35.58 |
2019-03-31 | $3.2M | 95k | 33.67 |
2018-12-31 | $2.2M | 66k | 32.92 |
2018-09-30 | $6.8M | 111k | 60.94 |
2018-06-30 | $4.6M | 95k | 48.83 |
2018-03-31 | $19M | 183k | 106.27 |
2017-12-31 | $1.8M | 33k | 55.56 |
2017-09-30 | $867k | 36k | 24.00 |
2017-06-30 | $959k | 49k | 19.56 |
2017-03-31 | $2.4M | 100k | 23.47 |
2016-12-31 | $280k | 23k | 12.26 |
2016-09-30 | $19k | 1.1k | 16.90 |
2016-06-30 | $50k | 3.5k | 14.54 |
2016-03-31 | $60k | 4.4k | 13.67 |
2015-12-31 | $72k | 4.3k | 16.80 |
2015-09-30 | $45k | 4.1k | 10.80 |
2015-03-31 | $330k | 30k | 11.20 |